CCME Global, a company in the Biotechnology industry, reported revenue of ₹0.23 crore and a net loss of ₹0.22 crore for the September 2026 quarter.
CCME Global (BSE: CCME) closed at ₹35.19 on 20 Nov 2026, down 78.2% over the past year. Its market capitalisation is ₹159 crore.
CCME Global Ltd, formerly Genesis IBRC India Ltd and SSK Lifestyles Ltd, is transitioning from a non-operational biotechnology business towards FMCG, commodities, and minerals trading, manufacturing, and import-export activities under new management.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.